John Carlos Lantis

Dr. John Carlos Lantis

Division of Vascular Surgery, Department of Surgery, The Icahn School of Medicine at Mount Sinai, New York, NY, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in WOUNDS: A Compendium of Clinical Research and Practice
Verified
Journal Article
Closed access
JLJohn Carlos Lantis
John Carlos Lantis
ELEric Lullove
Eric Lullove
BLBrock Liden
Brock Liden
PMPatrick McEneaney
Patrick McEneaney
ARAllen Raphael
Allen Raphael
RHRuby Huynh
Ruby Huynh
Introduction. DFUs remain a cause of significant morbidity. Objective. This is the third of 3 planned articles reporting on a prospective, multicenter, randomized controlled trial evaluating the use of omega-3–rich acellular FSG compared with CAT in the management of DFUs. Materials and Methods. A total of 102 patients with a DFU (n = 51 FSG, n = 51 CAT) participated in the trial as ITT candidates, with 77 of those patients included in the PP analysis (n = 43 FSG, n = 34 CAT). Six months after treatment, patients with healed ulcers were followed up for ulcer recurrence. A cost analysis model was applied in both treatment groups. Results. The proportion of closed wounds at 12 weeks was compared, as were the secondary outcomes of healing rate and mean PAR. Diabetic foot wounds treated with FSG were significantly more likely to achieve closure than those managed with CAT (ITT: 56.9% vs 31.4%; P =.0163). The mean PAR at 12 weeks was 86.3% for FSG vs 64.0% for CAT (P =.0282). Conclusions. Treatment of DFUs with FSG resulted in significantly more wounds healed and an annualized cost savings of $2818 compared with CAT.

1 January 2022 in WOUNDS: A Compendium of Clinical Research and Practice
Verified
Journal Article
Closed access
ELEric Lullove
Eric Lullove
BLBrock Liden
Brock Liden
PMPatrick McEneaney
Patrick McEneaney
ARAllen Raphael
Allen Raphael
RKRobert Klein
Robert Klein
JLJohn Carlos Lantis
John Carlos Lantis
Objective. This is the second of 3 planned articles reporting on a prospective, multicenter, randomized controlled trial assessing the efficacy of fish skin graft in the management of diabetic foot ulcers in comparison with the standard of care (collagen alginate dressing). Materials and Methods. The primary end point of this prospective randomized trial is the number of closed wounds at 12 weeks. Results. As of the time of this writing, 94 patients had completed the protocol. At 12-week follow-up, healing was achieved in 63.0% of index ulcers (29 of 46 patients) in the acellular fish skin graft group compared with 31.3% in the control group (15 of 48 patients) (P =.0036). In both groups, the mean time to healing was 7 weeks. The median number of applications of the fish skin graft to achieve healing was 6. Conclusion. A clinically and statistically significant difference in healing was observed between patients treated with acellular fish skin graft and those treated with a collagen alginate dressing. The data support the completion of this prospective randomized trial.

1 January 2023 in WOUNDS: A Compendium of Clinical Research and Practice
Verified
Journal Article
Closed access
CHCallie Horn
Callie Horn
AFAllegra Fierro
Allegra Fierro
JLJohn Carlos Lantis
John Carlos Lantis
NPWT has probably been the most important addition to wound care in the current century. Despite this fact, its use in the treatment of VLUs remains very limited. This review first examines the documented and potential VLU wound environment changes that can be facilitated by NPWT. The data supporting the use of NPWT for VLU wound bed preparation, the management of fluid drainage, and the bolstering of skin grafts are evaluated. The similarities and differences between suNPWT, traditional NPWT, and NPWTi are outlined. Included in this review is when and where each therapy may have a place in the treatment of VLUs. Finally, a brief algorithm to enhance the use of NPWT in the treatment of VLUs is presented.

6 September 2018
Verified
Book Chapter
Closed access
PDF file
JLJohn Carlos Lantis
John Carlos Lantis
JPJuan A. Paredes
Juan A. Paredes

1 January 2023 in WOUNDS: A Compendium of Clinical Research and Practice
Verified
Journal Article
Closed access
ATAnthony Tickner
Anthony Tickner
FAFrank Aviles
Frank Aviles
RKRobert Kirsner
Robert Kirsner
ELEric Lullove
Eric Lullove
LMLeah Main
Leah Main
JLJohn Carlos Lantis
John Carlos Lantis
Background. Since 2017, the clinical use of IFSG has increased substantially in the United States, with some use in Europe and Asia as well. However, scant consensus data have been published on such use. Objective. The authors sought to develop consensus recommendations for the clinical use of IFSG in the management of acute and chronic LEWs. Methods. A panel of 8 expert clinicians in the United States used a 2-cycle NFG process to develop consensus statements based on their own clinical practice and the literature. At their initial meeting in October 2021, panel members discussed the management of DFUs, VLUs, atypical LEWs, and traumatic LEWs in their practices. Consensus statements were drafted, voted on, and rated by relative importance. At the second meeting in October 2022, the panel discussed the initial survey results; a second survey was conducted, and panel members revised the recommendations and indicated the relative importance of each in the final report. A systematic literature review of English-language articles published from January 2016 through November 2022 was conducted as well, using the search terms: “fish skin,” “piscine graft,” “fish tissue,” “intact fish skin graft,” “Cod skin,” “Omega 3 fatty acid graft.” Results. Forty-three statements were generated and grouped into 5 sections comprising general recommendations for LEWs and recommendations specific to DFUs, VLUs, atypical LEWs, and traumatic LEWs. The primary general recommendation is the need to determine wound etiology based on clinical evaluation and reviewing related test results. For DFUs and VLUs, the main recommendations are to adhere to first-line therapy (ie, standard of care, follow conventional guidelines [multilayer compression therapy], offloading, and assessment of wound perfusion) before introducing IFSG. Conclusions. Publications on and clinical experience in the use of IFSGs have increased substantially in the past several years. The 43 consensus recommendations are meant to guide physicians in the optimal use of IFSG in the management of acute and chronic LEWs.

10 October 2022 in Wound Repair and Regeneration
Verified
Journal Article
Closed access
DMDavid J. Margolis
David J. Margolis
NMNandita Mitra
Nandita Mitra
OHOle Hoffstad
Ole Hoffstad
DMDonald Scot Malay
Donald Scot Malay
ZMZiad K. Mirza
Ziad K. Mirza
STStephen Raymond Thom
Stephen Raymond Thom